Subsequent Disclosure. Notwithstanding the foregoing, to the extent information regarding this Agreement or the Product has already been publicly disclosed, either Party (or its Affiliates) may subsequently disclose the same information to the public without the consent of the other Party.
Appears in 13 contracts
Samples: Neurology Drug Discovery and Development Collaboration, Option and License Agreement (Ionis Pharmaceuticals Inc), Research Collaboration, Option and License Agreement (Ionis Pharmaceuticals Inc), Strategic Neurology Drug Discovery and Development Collaboration, Option and License Agreement (Ionis Pharmaceuticals Inc)
Subsequent Disclosure. Notwithstanding the foregoing, to the extent information regarding this Agreement or the a Product has already been publicly disclosed, either Party (or its Affiliates) may subsequently disclose the same information to the public without the consent of the other Party.
Appears in 12 contracts
Samples: Collaboration and Option Agreement, Research, Development, and License Agreement (Ionis Pharmaceuticals Inc), HTT Research, Development, Option and License Agreement (Ionis Pharmaceuticals Inc)
Subsequent Disclosure. Notwithstanding the foregoing, to the extent information regarding this Agreement or the a Licensed Product has already been publicly disclosed, either Party (or its Affiliates) may subsequently disclose the same information to the public without the consent of the other PartyParty so long as such information remains true, correct and the most current information with respect to the subject matters set forth therein.
Appears in 1 contract
Samples: Collaboration and License Agreement (Ionis Pharmaceuticals Inc)
